Pharmaceuticals, Biotechnology and Life Sciences
New Nature Genetics publication describes novel high-throughput single-cell ChIP-seq approach to studying heterogeneity of chromatin states within complex biological systems…
CHENGDU, China–(BUSINESS WIRE)–HitGen Inc. today announced that it has entered into a drug discovery research collaboration with Gilead Sciences to…
SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer, autoimmune/inflammatory, and…
Company Also Reports Q1 2019 Financial Results TORONTO–(BUSINESS WIRE)–#FSDDF–The Board of Directors of FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF)…
–First Investigational Therapy in a Pivotal Trial to Address Unmet Need for Patients with Advanced Urothelial Cancer After Treatment with…
Data Presented at European Academy of Allergy and Clinical Immunology Congress OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today…
CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–#AANAM–Exicure, Inc. (OTCQB: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid…
The world’s premier life sciences event returns to Philadelphia for four days of inspiring keynote speeches, fireside chats and educational…
Phase III study protocol for Namodenoson in the treatment of advanced liver cancer patients is now being prepared and will…
Ablexis grants rights to use the AlivaMab™ Mouse platform for research, development and potential commercialization of antibodies SAN DIEGO–(BUSINESS WIRE)–Ablexis,…